Pulmonary alveolar proteinosis associated with dust inhalation: Not secondary but autoimmune?

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 5, 2010, Pages 427-428

  Costabel, Ulrich ^a   Nakata, Koh ^b  

^a RUHRLANDKLINIK   (Germany)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDIUM TIN OXIDE;

AUTOIMMUNE DISEASE; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DUST EXPOSURE; EDITORIAL; HUMAN; LUNG ALVEOLUS PROTEINOSIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK FACTOR;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; DUST; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INDIUM; INHALATION EXPOSURE; OCCUPATIONAL EXPOSURE; PULMONARY ALVEOLAR PROTEINOSIS;

EID: 77649154305     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200912-1800ED     Document Type: Editorial

References (13)

1. Kitamura T, Tanaka N, Watanabe J, Uchida K, Kanegasaki S, Yamada Y, Nakata K. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/ macrophage colony-stimulating factor. J Exp Med 1999;190: 875-880.
2. Uchida K, Nakata K, Trapnell BC, Terakawa T, Hamano E, Mikami A, Matsuhita I, Seymour JF, Oh-Eda M, Ishige I, et al. High affinity autoantibodies specifically eliminate granulocytemacrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 2004;103:1089-1098.
3. Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ichiwata T, et al.; Japanese Center of the Rare Lung Diseases Consortium. Characteristics of a large cohort of autoimmune pulmonary alveolar proteinosis patients in Japan. Am J Respir Crit Care Med 2008;177:752-762.
4. Buechner HA, Ansari A. Acute silico-proteinosis. A new pathologic variant of acute silicosis in sandblasters, characterized by histologic features resembling alveolar proteinosis. Dis Chest 1969;55:274-278.
5. Keller CA, Frost A, Cagle PT, Abraham JL. Pulmonary alveolar proteinosis in a painter with elevated pulmonary concentrations of titanium. Chest 1995;108:277-280.
6. Miller RR, Churg AM, Hutcheon M, Lam S. Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 1984; 130:312-315.
7. Mc Cunney RJ, Godefroi R. Pulmonary alveolar proteinosis and cement dust: a case report. J Occup Med 1989;31:233-237.
8. Ray SL, Salm R. A fatal case of pulmonary alveolar proteinosis. Thorax 1962;17:257-266.
9. Cummings KJ, Donat WE, Ettensohn DB, Roggli VL, Ingram P, Kreiss K. Pulmonary alveolar proteinosis in workers at an indium processing facility. Am J Respir Crit Care Med 2010;181:458-464.
10. Ishii H, Trapnell BC, Tazawa R, Inoue Y, Akira M, Kogure Y, Tomii K, Takada T, Hojo M, Ichiwata T, et al. Comparitive study of highresolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest 2009;136:1348-1355.
11. Lison D, Laloy J, Corazzari I, Muller J, Rabolli V, Panin N, Huaux F, Fenoglio I, Fubini B. Sintered indium-tin-oxide (ITO) particles: a new pneumotoxic entity. 2009;108:472-481.
12. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002;166:215-235.
13. Cooper GS, Miller FW, Germolec DR. Occupational exposures and autoimmune diseases. Int Immunopharmacol 2002;2:303-313.